BackBeximco Pharmaceuticals Limited Overview

Beximco Pharmaceuticals Limited Net Tangible Assets

Beximco Pharmaceuticals Limited's net tangible assets is $63B.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$63.08B
↑ 15.86% YoYΔ $8.63B vs prior year quarter

Peer trimmed avg / median

Loading

Beximco Pharmaceuticals Limited Net Tangible Assets History

Loading

Beximco Pharmaceuticals Limited vs. peers: Net Tangible Assets Comparison

Loading

Beximco Pharmaceuticals Limited Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Beximco Pharmaceuticals Limited (BXP.L) FAQ

As of the most recent data (March 2026), BXP.L shows a net tangible assets of $63B. That compares with $54B in the prior-year period — up 15.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BXP.L's net tangible assets is now $63B (was $54B) — a 15.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Beximco Pharmaceuticals Limited is outperforming or lagging.

Tracking BXP.L's net tangible assets over time shows whether Beximco Pharmaceuticals Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $63B That compares with $54B in the prior-year period — up 15.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Beximco Pharmaceuticals Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $63B) with ownership activity and broader fundamentals.